Rockwell Medical (RMTI) vs Shuttle Pharmaceuticals (SHPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Rockwell Medical (RMTI) has outperformed Shuttle Pharmaceuticals (SHPH) over the past year, losing 33.7% versus a loss of 87.4%. Rockwell Medical is the larger company by market cap ($32.3 million vs $26.4 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RMTI | SHPH |
|---|---|---|
| Share price | $8.02 | $5.55 |
| Market cap | $32.32M | $26.44M |
| 1-day change | -2.43% | +17.83% |
| YTD return | -3.37% | -69.17% |
| 1-year return | -33.72% | -87.36% |
| 5-year return | -87.85% | — |
| Forward P/E | 114.57 | — |
| EPS (TTM) | $-1.34 | $-16.87 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.90 | $55.90 |
| 52-week low | $4.89 | $2.58 |
| Distance from 52-week high | -37.83% | -90.07% |
| Analyst consensus | none | — |
| Avg. price target upside | +149.38% | — |
| Average volume | 26.80K | 1.36M |
| Shares outstanding | 4.03M | 4.76M |
| Employees | 157 | 2 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RMTI has outperformed SHPH by 53.6 percentage points over the past year.
About Rockwell Medical
RMTI stock →Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers.
Healthcare · Drug Manufacturers - Specialty & Generic · 157 employees
About Shuttle Pharmaceuticals
SHPH stock →Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development.
Healthcare · Drug Manufacturers - Specialty & Generic · 2 employees
RMTI vs SHPH FAQ
Which is bigger, Rockwell Medical or Shuttle Pharmaceuticals?
Rockwell Medical (RMTI) is larger, with a market capitalization of $32.32M compared with $26.44M for Shuttle Pharmaceuticals (SHPH).
Which stock has performed better over the past year, RMTI or SHPH?
RMTI returned -33.72% over the past 12 months, compared with -87.36% for SHPH (price return, excluding dividends). Past performance does not predict future results.
Are Rockwell Medical and Shuttle Pharmaceuticals in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.